Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00601341 · ClinicalTrials.gov registry record · NA

Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response

A NA study, sponsored by University of Virginia.

Terminated
Registry status
NA
Development phase
106
Enrollment target

NCT00601341: Clinical Trial NA study, sponsored by University of Virginia.

NCT00601341 is a NA study that was terminated before completion, run by University of Virginia. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00601341, a NA study, was terminated before completion, sponsored by University of Virginia.

TERMINATED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

The purpose of this study is to gain a better understanding of the effects of lumbopelvic manual therapy on lower extremity biomechanics and arthrogenic muscle response. As a result of this study, we also hope that physical therapists, athletic trainers, and other physical medicine rehabilitation providers will gain a better understanding of lower extremity injuries and have the scientific evidence to provide patients with techniques which would allow for efficient return to activities of daily living without restrictions and possibly prevent future injuries and minimize risk of osteoarthritis. The objectives of this study are to: * Determine the amount and duration of arthrogenic muscle response of quadriceps muscles following lumbopelvic joint manipulation. * Determine the effects of lumbopelvic joint manipulation on temporospatial parameters of gait such cadence, step length, velocity and mean peak lower extremity joint moments. * Determine if a correlation exists between patellofemoral joint pain and lumbopelvic joint dysfunction. * Determine the amount of change in clinical outcome measure scores following lumbopelvic joint manipulation.

Interventions

  • OTHER No active intervention
  • OTHER lumbosacral joint manipulation
  • OTHER lumbar passive range of motion

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2005-05
Est. Completion 2009-11
Phase NA
University of Virginia

449 total trials

Why NCT00601341 stopped before completion

NCT00601341 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 3 interventions - of which No active intervention is the first listed.

NCT00601341 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00601341 about?

NCT00601341 is a clinical study titled "Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response". The purpose of this study is to gain a better understanding of the effects of lumbopelvic manual therapy on lower extremity biomechanics and arthrogenic muscle response. As a result of this study, we also hope that physical therapists, athletic trainers, and other physical medicine rehabilitation pr...

What is the current status of trial NCT00601341?

This trial is currently terminated. It is a NA study. The enrollment target is 106 participants. The study started on 2005-05. Estimated completion is 2009-11.

What interventions are being tested in trial NCT00601341?

The interventions under investigation include: No active intervention (OTHER), lumbosacral joint manipulation (OTHER), lumbar passive range of motion (OTHER).

Who is sponsoring clinical trial NCT00601341?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00601341's enrollment target sits among peer trials

106 830th of 2000 higher than 1,167 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00601341, the US trial registry maintained by the National Library of Medicine. NCT00601341 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.